Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Wirsching

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|October 27, 2022
Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-HydroxylaseSebastian Wirsching, Michael Fichter, Maximiliano L Cacicedo, et al.
Journal of Materials Chemistry. B|October 22, 2021
Controlling the semi-permeability of protein nanocapsules influences the cellular response to macromolecular payloadsMarina Machtakova, Sebastian Wirsching, Stephan Gehring, et al.
Frontiers in Immunology|May 6, 2022
Long-Term, CD4<sup>+</sup> Memory T Cell Response to SARS-CoV-2Sebastian Wirsching, Laura Harder, Markus Heymanns, et al.
Frontiers in Immunology|December 14, 2018
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple MyelomaSara Tognarelli, Sebastian Wirsching, Ivana von Metzler, et al.
Frontiers in Pediatrics|September 30, 2022
OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cellsSebastian Wirsching, Marina Machtakova, Frauke Borgans, et al.
Nanoscale Horizons|August 4, 2021
Encapsulation of polyprodrugs enables an efficient and controlled release of dexamethasoneMengyi Li, Shuai Jiang, Adelina Haller, et al.
Nanoscale|January 16, 2020
Controlling protein interactions in blood for effective liver immunosuppressive therapy by silica nanocapsulesShuai Jiang, Domenik Prozeller, Jorge Pereira, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2022
mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse modelMaximiliano L Cacicedo, Christine Weinl-Tenbruck, Daniel Frank, et al.
Frontiers in Bioengineering and Biotechnology|October 24, 2022
Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in miceMaximiliano L Cacicedo, Christine Weinl-Tenbruck, Daniel Frank, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|October 27, 2022
Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-HydroxylaseSebastian Wirsching, Michael Fichter, Maximiliano L Cacicedo, et al.
Journal of Materials Chemistry. B|October 22, 2021
Controlling the semi-permeability of protein nanocapsules influences the cellular response to macromolecular payloadsMarina Machtakova, Sebastian Wirsching, Stephan Gehring, et al.
Frontiers in Immunology|May 6, 2022
Long-Term, CD4<sup>+</sup> Memory T Cell Response to SARS-CoV-2Sebastian Wirsching, Laura Harder, Markus Heymanns, et al.
Frontiers in Immunology|December 14, 2018
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple MyelomaSara Tognarelli, Sebastian Wirsching, Ivana von Metzler, et al.
Frontiers in Pediatrics|September 30, 2022
OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cellsSebastian Wirsching, Marina Machtakova, Frauke Borgans, et al.
Nanoscale Horizons|August 4, 2021
Encapsulation of polyprodrugs enables an efficient and controlled release of dexamethasoneMengyi Li, Shuai Jiang, Adelina Haller, et al.
Nanoscale|January 16, 2020
Controlling protein interactions in blood for effective liver immunosuppressive therapy by silica nanocapsulesShuai Jiang, Domenik Prozeller, Jorge Pereira, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2022
mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse modelMaximiliano L Cacicedo, Christine Weinl-Tenbruck, Daniel Frank, et al.
Frontiers in Bioengineering and Biotechnology|October 24, 2022
Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in miceMaximiliano L Cacicedo, Christine Weinl-Tenbruck, Daniel Frank, et al.
Pageof 1